NEW DELHI: In order to create an institutional framework for effective implementation, monitoring and evaluation of the policy, the Department of Pharmaceuticals under the Union Ministry of Chemicals and Fertilizers released on Friday guidelines on pharmaceutical innovation and entrepreneurship for academic institutions.
These policy directions aim to transform academic research into innovative and commercially applicable technologies. It will also create a strong ecosystem for entrepreneurial activities and contribute to India’s self-reliant mission.
The policy guidelines will encourage faculty, staff and students to pursue entrepreneurship. “These will help formulate policies and generate ideas across disciplines that can be transformed into successful technologies, products and services. It will further establish a mechanism for technology development and transfer and foster pharmaceutical innovation and entrepreneurship to foster unmet social impact therapeutic technologies that provide benefits to humanity,” according to a government statement.
Mansukh Mandaviya, Union Minister for Chemicals and Fertilizers, has endorsed these guidelines which have now been forwarded to all National Institutes of Pharmaceutical Education and Research (NIPER) for them to take further steps for their quick and efficient implementation.
The department has established the NIPERs as institutes of national significance to provide quality education and conduct high-level research.
NIPERs recently launched a joint search portal for industry and researchers. The institute has also prepared a joint research program based on national needs and their own expertise and facilities.
“The Department of Pharmaceuticals aims to promote India’s pharmaceutical sector as a global leader in quality medicines and to ensure the availability, accessibility and affordability of medicines and medical devices in the country. Therefore, the department focuses on research and development and innovation,” he said.
The department will also soon come up with a “Policy to Catalyze Research, Development and Innovation in the Pharma-MedTech Sector in India”.
